HRT Financial’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
HRT Financial's RGNX Position: Q2 2026 in Review
HRT Financial sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 351,489 shares — an estimated $2.94M sold.
HRT Financial first reported a position in RGNX in Q4 2019 and held it in 13 quarters. The position peaked at $4.32M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- HRT Financial reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
- HRT Financial sold 351,489 Regenxbio shares in Q2 2026, an estimated $2.94M.
- HRT Financial first reported a position in Regenxbio in Q4 2019 and held it in 13 quarters.
- HRT Financial's Regenxbio position peaked at $4.32M in Q4 2025.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.